|Bid||110.00 x 900|
|Ask||113.00 x 1300|
|Day's Range||105.33 - 112.88|
|52 Week Range||55.90 - 112.88|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov. 05, 2020 - Nov. 09, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||110.13|
Here's how much you'd have today if you had invested $10,000 in Guardant Health's IPO. Guardant Health operated as a privately held company for roughly six years before listing its shares on the Nasdaq stock exchange in October 2018. A $10,000 investment in Guardant Health's IPO would have allowed you to pick up 526 shares (and have a little money left over).
They're all innovative disruptors, but these three stocks could outperform Tesla over the next decade.
Cancer diagnostic specialist Grail today filed for an initial public offering (IPO) on the Nasdaq, with the stock to trade under the ticker symbol GRAL. In its 2019 round of funding, Grail's valuation was estimated at $3.2 billion. Grail was spun out of gene-sequencing giant Illumina (NASDAQ: ILMN) four years ago.